COST-EFFECTIVENESS OF EDOXABAN COMPARED WITH OTHER LICENSED NOACS FOR THE PREVENTION OF STROKE AND SYSTEMIC EMBOLIC EVENTS IN THE UK

被引：1

作者：

Claxton, L. ^{[1
]}

Taylor, M. ^{[2
]}

Lewis, L. ^{[2
]}

Alexandre, A. F. ^{[3
]}

Harrington, A. E. ^{[3
]}

Bakhai, A. ^{[4
,5
,6
]}

Brueggenjuergen, B. ^{[7
]}

机构：

[1] Univ York, York Hlth Econ Consortium, York, N Yorkshire, England

[2] York Hlth Econ Consortium, York, N Yorkshire, England

[3] Daiichi Sankyo Europe, Munich, Germany

[4] Royal Free Hosp, London, England

[5] Barnet Hosp, London, England

[6] Chase Farm Hosp, London, England

[7] Steinbeis Univ Berlin, Berlin, Germany

来源：

关键词：

D O I：

10.1016/j.jval.2015.09.895

中图分类号：

F [经济];

学科分类号：

020101 [政治经济学];

摘要：

PCV126

引用

页码：A396 / A396

页数：1